3.300
+0,00%
2026-10-09
Fundamental Analysis
41 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -13.3% | -65.5% | 0 / 3 | +2.6% | +0.53 pp | -0.29 pp | +23.1% | -1.65 | — | 1.089 | +2,6% | −89,8 | −6,3% | — | -0.40 | — |
| Pts | 0 | 0 | 0 | 0 | 8 | 4 | 12 | 12 | 8 | |||||||
Valuation annotation:Price: 3.300 (close price on 2026-10-09)EPS (TTM): −12.479,3
Financial charts
1.Revenue & growth
VND bn1.089Q2/26
1.Revenue & growth
VND bn1.089Q2/26
2.Profit & growth
VND bn-103Q2/26
3.Profit mix (Penman)
VND bn-650Q2/26
4.Margins & cost structure
%1.1%Q2/26
5.Returns & cash cycle
% · days-8.6%Q2/26
6.Earnings quality & cash
VND bn-396Q2/26
7.Asset structure
VND bn4.726Q2/26
8.Funding & debt health
VND bn · times4.726Q2/26
9.Revenue backlog
VND bn700Q2/26
10.Valuation
times · %-0,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-1.881Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
No comparable quarter a year earlier
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26